Add office photos
Engaged Employer
Zydus Lifesciences

4.1
based on 6.3k Reviews
Video summary
Company Overview
Associated Companies
Company Locations
Working at Zydus Lifesciences
Company Summary
In 1995 we dedicated ourselves to the welfare of people and depicted our commitment with a heart-to-heart portrait. Today, with our evolved brand identity, this commitment emerges stronger than ever.
Overall Rating
4.1/5
based on 6.3k reviews

5% above
industry average

Highly rated for
Salary, Job security, Skill development
Work Policy

Work from office
83% employees reported

Monday to Saturday
60% employees reported

Strict timing
56% employees reported

No travel
48% employees reported
View detailed work policy
Top Employees Benefits
Job/Soft skill training
358 employees reported
Office cab/shuttle
349 employees reported
Health insurance
326 employees reported
Cafeteria
128 employees reported
View all benefits
About Zydus Lifesciences
Founded in1952 (73 yrs old)
India Employee Count10k-50k
Global Employee Count10k-50k
India HeadquartersAhmedabad, India, India
Websitezyduslife.com
Primary Industry
Other Industries

View in video summary
Zydus Lifesciences Limited formerly knowns as Cadila Healthcare Limited, a leading Indian Pharmaceutical company is a fully integrated, global healthcare provider. With in-depth domain expertise in the field of healthcare, it has strong capabilities across the spectrum of the pharmaceutical value chain. From formulations to active pharmaceutical ingredients. Zydus has earned a reputation amongst Indian pharmaceutical companies for providing comprehensive and complete healthcare solutions. One of the salient features of Zydus is its rich history and lineage. The origin of the company dates all the way back to the 1950s. The company was founded in the year 1952 by Mr. Ramanbhai B. Patel (late), a first-generation entrepreneur and a doyen in the field of Indian Pharmaceuticals. In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble turnover of Rs. 250 crores in 1995 the group witnessed significant financial growth and registered a turnover of over Rs. 15,000 crores in FY-21. Adhering to its brand promise of being dedicated to life in all its dimensions, Zydus continues to innovate with an unswerving focus to address unmet healthcare needs. Simultaneously it rededicates itself to its mission of creating healthier, happier communities across the globe.
Mission: To unlock new possibilities in life-sciences through quality healthcare solutions that impact lives.
Vision: To be a global life-sciences company transforming lives through pathbreaking discoveries.
Zydus Lifesciences Ratings
based on 6.3k reviews
Overall Rating
4.1/5
How AmbitionBox ratings work?
5
3.3k
4
1.6k
3
697
2
277
1
468
Category Ratings
4.0
Salary
3.9
Job security
3.9
Skill development
3.8
Company culture
3.8
Work-life balance
3.8
Work satisfaction
3.7
Promotions
Zydus Lifesciences is rated 4.1 out of 5 stars on AmbitionBox, based on 6.3k company reviews. This rating reflects a generally positive employee experience, indicating satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at Zydus Lifesciences
based on 5.7k reviews
4.0
Rated by 402 Women
Rated 4.0 for Job security and 3.9 for Skill development
4.0
Rated by 5.3k Men
Rated 4.0 for Salary and 3.9 for Skill development
Work Policy at Zydus Lifesciences
based on 728 reviews in last 6 months
Work from office
83%
Hybrid
11%
Permanent work from home
6%
Zydus Lifesciences Reviews
Top mentions in Zydus Lifesciences Reviews
+ 5 more
Compare Zydus Lifesciences with Similar Companies
Change Company | Change Company | Change Company | ||
---|---|---|---|---|
Overall Rating | 4.1/5 based on 6.3k reviews | 4.0/5 based on 7.1k reviews | 4.1/5 based on 6.4k reviews | 4.1/5 based on 7.2k reviews |
Highly Rated for | Salary Skill development Job security | Skill development Company culture Work-life balance | Skill development Company culture Work-life balance | Skill development Salary Work-life balance |
Critically Rated for | No critically rated category | Promotions | No critically rated category | No critically rated category |
Primary Work Policy | Work from office 83% employees reported | Work from office 74% employees reported | Work from office 85% employees reported | Work from office 73% employees reported |
Rating by Women Employees | 4.0 Good rated by 402 women | 4.0 Good rated by 812 women | 4.0 Good rated by 387 women | 4.0 Good rated by 730 women |
Rating by Men Employees | 4.0 Good rated by 5.3k men | 4.0 Good rated by 6k men | 4.1 Good rated by 5.7k men | 4.1 Good rated by 6.1k men |
Job security | 3.9 Good | 3.5 Good | 3.7 Good | 3.7 Good |
View more
Zydus Lifesciences Salaries
Zydus Lifesciences salaries have received with an average score of 4.0 out of 5 by 6.3k employees.
Deputy Manager
(909 salaries)
Unlock
₹7.8 L/yr - ₹20 L/yr
Officer
(826 salaries)
Unlock
₹1.2 L/yr - ₹6.7 L/yr
Technical Assistant
(304 salaries)
Unlock
₹1.9 L/yr - ₹9 L/yr
Production Officer
(217 salaries)
Unlock
₹1.2 L/yr - ₹5.4 L/yr
Research Associate
(217 salaries)
Unlock
₹1.6 L/yr - ₹10.3 L/yr
Area Business Manager
(206 salaries)
Unlock
₹3.8 L/yr - ₹11.2 L/yr
Senior Associate
(193 salaries)
Unlock
₹2.7 L/yr - ₹11.2 L/yr
Medical Representative
(171 salaries)
Unlock
₹2.1 L/yr - ₹5.9 L/yr
Executive Production
(162 salaries)
Unlock
₹3.1 L/yr - ₹7.5 L/yr
Therapy Manager
(144 salaries)
Unlock
₹3.4 L/yr - ₹11.2 L/yr
Zydus Lifesciences Interview Questions
A Plant Operator was asked 1mo agoQ. What is meant by servo
A Technical Assistant was asked 7mo agoQ. What is PLC full form
An Executive was asked 1mo agoQ. How do you ensure the accuracy and reliability of QC test results ?
An Executive Production was asked 25 Oct 2022Q. Bernoulli s equation?
A Hvac Operator was asked 20 Apr 2022Q. Why parformance varification take?
Zydus Lifesciences Jobs
Popular Designations Zydus Lifesciences Hires for
Popular Skills Zydus Lifesciences Hires for
Current Openings
Zydus Lifesciences News
View all
Stocks To Watch Today: L&T, Biocon, Titan, Kalyan Jewellers, Britannia, Union Bank
- Lupin, Mahindra & Mahindra Financial Services, Brigade Enterprises, Tata Motors, Infosys, Bharat Petroleum Corp, Oil & Natural Gas Corp, Gensol Engineering, Birla Corp, Zydus Lifesciences, Reliance Industries are some companies in focus.
- Recent developments include Tata Motors merging Tata Motors Finance, Infosys dissolving its Mexican subsidiary, and BPCL winning wind farm projects in Madhya Pradesh and Maharashtra.
- Stock highlights show L&T's strong Q4FY25 results with revenue, Ebitda, and net profit growth, while Union Bank of India reports a significant increase in net profit in Q4FY25.
- Biocon, Titan, Britannia, Kalyan Jewellers have showcased positive Q4FY25 results with revenue growth, improved margins, and increased net profits.
- Other companies like Aarti Industries, Zee Entertainment, Rain Industries, Fine Organics have also reported their Q4FY25 results reflecting revenue, Ebitda, and net profit changes.
- The article provides insights on key financial metrics, business developments, and market actions of various companies in the current trading cycle.
- Overall, the stocks to watch today include those of L&T, Biocon, Titan, Kalyan Jewellers, Britannia, and Union Bank, with a focus on their quarterly performance and market dynamics.
Bloomberg Quint | 9 May, 2025

Stocks To Buy Today: TVS Motor, Prestige Estate, Zydus Among Others
- TVS Motor, Prestige Estate, and Zydus Lifesciences are among the stocks recommended to buy.
- TVS Motor stock is recommended with a target price of Rs 2,850 and a stop loss at Rs 2,745.
- Container Corporation of India is suggested to buy with a target price of Rs 710 and a stop loss at Rs 677.
- Prestige Estates Projects has a 'buy' recommendation with a target price of Rs 1,350.
Bloomberg Quint | 29 Apr, 2025

Stocks To Watch Today: RIL, HCLTech, Force Motors, L&T Finance, Tejas Networks
- Stocks to watch today include RIL, HCLTech, Force Motors, L&T Finance, Tejas Networks, RBL Bank, Tata Technologies, and Poonawala Fincorp.
- Key updates include HCL Technologies acquiring KHY E4lectronics, GAIL signing an MoU with Container Corp., and Axis Bank announcing a change in management.
- Other highlights involve Aditya Birla Sun Life planning to raise funds, Apollo Tyres closing operations in the Netherlands, and Mahindra & Mahindra acquiring SML Isuzu.
- Additionally, Aurobindo Pharma's positive opinion on Dazublys®, Zydus Lifesciences' inspection by USFDA, and Biocon's biosimilar approval by EMA were noted.
- Companies like Harsha Engineers, Alembic Pharma, and Eicher Motors introduced new facilities and products, while Railtel Corp received an order from The Institute of Road Transport.
- Post-market earnings highlighted performance by RBL Bank, Reliance Jio, Reliance Industries, Tata Technologies, DCB Bank, Poonawala Fincorp, Rossari Biotech, Oracle Financial Services, and others.
- Notable financial results included Force Motors' revenue and profit growth, LT Finance's increase in revenue and net profit, and Tejas Networks' decline in EBITDA and net profit.
- Further details on companies like Zensar Tech, Lloyds Metals and Energy, IDFC First Bank, MRPL, India Cements, Ugro Capital, SBFC Finance, IGL, and others were also provided.
- Earnings announcements to watch included UltraTech Cement, Aditya Birla Sun Life AMC, Castrol India, CSB Bank, Firstsource Solutions, Go Digit General Insurance, and more.
- The article covers various company updates, financial performances, and upcoming earnings reports to watch in the current market scenario.
- For more detailed information, readers can refer to the original article on NDTV Profit.
Bloomberg Quint | 28 Apr, 2025

Heard On The Street: Dealers Spot Action In IIFL Finance, Zydus Life, Lupin And Select IT Stocks
- IIFL Finance witnessed strong domestic institutional buying.
- Zydus Life and Lupin received positional buy calls in multiple dealing rooms.
- IT stocks like Tech Mahindra and Coforge attracted investor focus.
- Delivery-based buying continued in select IT names.
Bloomberg Quint | 22 Apr, 2025

Stocks To Watch Today: Infosys, HDFC Bank, ICICI Bank, Adani Ports, GAIL, Kolte-Patil Developers
- Stocks to watch today include Infosys, HDFC Bank, ICICI Bank, Adani Ports, GAIL, and Kolte-Patil Developers.
- Other stocks in focus before trading are Divi’s Laboratories, Zydus Lifesciences, and Tata Consultancy Services.
- Adani Ports announced acquisitions in Australia to boost cargo capacity significantly by 2030.
- Kolte-Patil Developers reported impressive fiscal 2025 sales and growth in project launches and collections.
- Zydus Lifesciences and Divi's Laboratories entered strategic agreements for technology commercialization and capacity expansion.
- GAIL faces a review of its integrated network tariff by the Petroleum and Natural Gas Regulatory Board.
- HDFC Bank and ICICI Bank posted their Q4FY25 earnings with positive growth in net profit and NPA figures.
- Yes Bank, HDFC Life Insurance, Infosys, Tata Elxsi, and other companies shared their financial results for Q4FY25.
- Earnings of companies like Mastek Ltd., Just Dial, Jio Financial Services, and more were also highlighted.
- Various developments, appointments, acquisitions, and financial outcomes across different sectors were reported for the day.
Bloomberg Quint | 21 Apr, 2025

Zydus, Lupin Shares: Systematix Retains Hold, Cuts Target Price Over US Court Ruling In Myrbetriq Patent Case
- The US Court ruling in the Myrbetriq patent case has led Systematix to retain a hold rating on shares of Zydus and Lupin.
- Systematix has also cut the target price due to the court ruling which blocks the sale of generic versions of Myrbetriq in the US until the patent expires in March 2030.
- Lupin and Zydus Life had filed ANDAs with the USFDA to market generic versions of Myrbetriq, but their plans have been halted by the court ruling.
- The patent challenge made by Lupin and Zydus Life was rejected by the US District Court for the District of Delaware.
Bloomberg Quint | 17 Apr, 2025

Stock Recommendations Today: Wipro, Adani Ports, Angel One, Bharti Airtel, IndiGo On Brokerages' Radar
- Wipro Ltd. faced negative brokerage commentary after issuing weaker-than-expected revenue guidance and highlighting client uncertainty due to global tariff concerns.
- Brokerages like Citi, BofA Securities, and Investec trimmed price targets and earnings estimates for Wipro, anticipating another challenging year for the tech major.
- Morgan Stanley adjusted targets for consumer discretionary names, supporting disruptors like Trent Ltd. and raising price targets for Interglobe Aviation Ltd. in the travel sector.
- Analysts shared their recommendations on various stocks, with Citi retaining a 'sell' rating on Wipro and BofA Securities expecting a growth catch-up in the future.
- Morgan Stanley analyzed companies like Vedant Fashions, Aditya Birla Fashion, Trent, and Brainbees Solutions within the consumer discretionary segment, favoring businesses with strong competitive advantages.
- Adani Ports received positive feedback from Morgan Stanley for its resilient business model and strategy to reduce Ebitda sensitivity to cargo volumes.
- Angel One was recommended as a 'buy' by Investec, with noted earnings growth weaknesses in the upcoming fiscal year.
- HSBC raised the price target on InterGlobe Aviation and noted strong trading trends in the travel and hospitality sector.
- Bharti Airtel was highlighted by Bernstein as a top pick in the telecom sector, supported by strong defensive attributes and ongoing deleveraging.
- UBS shared insights on the Mirabegron litigation outcome, indicating potential challenges for Zydus and Lupin in the pharmaceutical space.
Bloomberg Quint | 17 Apr, 2025

Stock Market Today: All You Need To Know Going Into Trade On April 17
- Indian benchmark indices closed higher for the third consecutive session with NSE Nifty 50 up by 0.47% and BSE Sensex up by 0.4% on Wednesday.
- Foreign portfolio investors continued as net buyers of Indian equities, while domestic institutional investors were net sellers on Wednesday.
- Key earnings post-market hours included updates from companies like Wipro, Waaree Renewable Technologies, Angel One, and GTPL Hathway.
- Stocks to watch include Zydus Lifesciences, Lupin, One 97 Communications, Gensol Engineering, UltraTech Cement, DLF, and others.
- Notable market developments include ongoing investments, acquisitions, agreements, dividend announcements, and trading tweaks in various companies.
- Bulk/block deals involved companies like Gensol Engineering and Sami Hotels, with trading tweaks seen in securities like Garware Hi-Tech Films Ltd.
- In the F&O segment, Nifty April Futures rose, open interest fell, and specific securities were put under the F&O ban category.
- The Indian rupee strengthened against the US dollar, closing at 85.68 on Wednesday, supported by factors like easing inflation and lower oil prices.
- Overall, the stock market landscape showed positive movements in key indices and various corporate actions influencing investor sentiment.
- Market participants should closely monitor these developments and company-specific news for potential investment opportunities or risks.
Bloomberg Quint | 17 Apr, 2025

Zydus Lifesciences Share Price Spikes On Acquisition, New Drug Approval
- Zydus Lifesciences' share price advanced after the company's announced its latest acquisition update. The drugmaker has received the USFDA's final approval to manufacture a corticosteroid medication called Deflazacort to treat Duchenne muscular dystrophy. The company's share price rose by 2.41% to Rs 889.80 apiece, and it has fallen 7.09% on a year-to-date basis.
Bloomberg Quint | 15 Apr, 2025

Stock Market Live: GIFT Nifty Implies Muted Open; ICICI Bank, HCLTech, Zydus Life Share Prices In Focus
- The NSE Nifty IT may rise in Tuesday's session as the US President Donald Trump granted exemption to certain electronic products and components.
- GIFT Nifty 50 and BSE Sensex may see a muted open on Tuesday.
- ICICI Bank Ltd., HCLTech Ltd., and Zydus Lifesciences Ltd. will be in focus.
- Gold prices trading just shy of the record high as traders assess the US tariff outlook.
Bloomberg Quint | 15 Apr, 2025

Powered by
Zydus Lifesciences Subsidiaries
Zydus Healthcare
4.0
• 671 reviews
Zydus Hospital
4.3
• 257 reviews
German Remedies
4.0
• 90 reviews
Zydus Animal Health
3.8
• 62 reviews
Liva Pharmaceuticals
3.6
• 39 reviews
Zydus Pharmaceuticals
4.5
• 14 reviews
Report error
Compare Zydus Lifesciences with

Sun Pharmaceutical Industries
4.0

Aurobindo Pharma
4.0

Intas Pharmaceuticals
4.1

Macleods Pharmaceuticals
3.6

Hetero
3.8

Viatris
4.1

Alembic Pharmaceuticals
4.0

Abbott
4.1

Glenmark Pharmaceuticals
3.9

Ipca Laboratories
3.9

Alkem Laboratories
3.9

Torrent Pharmaceuticals
3.9

Mankind Pharma
3.9

MSN Laboratories
3.7

Ajanta Pharma
4.0

Akums Drugs & Pharmaceuticals Limited
4.3

GlaxoSmithKline Pharmaceuticals
4.1

Pfizer
3.9

DIVI'S Laboratories
3.7

Wockhardt
3.8
Contribute & help others!
You can choose to be anonymous
Companies Similar to Zydus Lifesciences

Cipla
Manufacturing, Pharma
4.1
• 7.2k reviews

Dr. Reddy's
Clinical Research, Pharma
4.0
• 7.1k reviews

Lupin
Biotech & Life sciences, Manufacturing, Pharma
4.1
• 6.4k reviews

Aurobindo Pharma
Healthcare / Pharma, Biotechnology, Pharma
4.0
• 5k reviews

Intas Pharmaceuticals
Biotech & Life sciences, Pharma
4.1
• 3.7k reviews

Macleods Pharmaceuticals
Biotech & Life sciences, Pharma
3.6
• 3.5k reviews

Alembic Pharmaceuticals
Real Estate, Engineering & Construction, Biotechnology, Pharma
4.0
• 3.3k reviews

Abbott
Healthcare / Pharma, Media & Entertainment / Publishing, Pharma
4.1
• 3.2k reviews

Glenmark Pharmaceuticals
Pharma
3.9
• 3.1k reviews

Ipca Laboratories
Pharma
3.9
• 3.1k reviews
Zydus Lifesciences FAQs
When was Zydus Lifesciences founded?
Zydus Lifesciences was founded in 1952. The company has been operating for 73 years primarily in the Pharma sector.
Where is the Zydus Lifesciences headquarters located?
Zydus Lifesciences is headquartered in Ahmedabad, India. It operates in 2 cities such as Ahmedabad, Mumbai. To explore all the office locations, visit Zydus Lifesciences locations.
How many employees does Zydus Lifesciences have in India?
Zydus Lifesciences currently has more than 26,000+ employees in India. Production, Manufacturing & Engineering department appears to have the highest employee count in Zydus Lifesciences based on the number of reviews submitted on AmbitionBox.
Does Zydus Lifesciences have good work-life balance?
Zydus Lifesciences has a Work-Life Balance Rating of 3.8 out of 5 based on 6,200+ employee reviews on AmbitionBox. 77% employees rated Zydus Lifesciences 4 or above, while 23% employees rated it 3 or below on work-life balance. This indicates that the majority of employees feel a generally balanced work-life experience, with some opportunities for improvement based on the feedback. We encourage you to read Zydus Lifesciences work-life balance reviews for more details
Is Zydus Lifesciences good for career growth?
Career growth at Zydus Lifesciences is rated fairly well, with a promotions and appraisal rating of 3.7. 77% employees rated Zydus Lifesciences 4 or above, while 23% employees rated it 3 or below on promotions/appraisal. Though the sentiment is mixed for career growth, majority employees have rated it positively. We recommend reading Zydus Lifesciences promotions/appraisals reviews for more detailed insights.
What are the pros of working in Zydus Lifesciences?
Working at Zydus Lifesciences offers several advantages that make it an appealing place for employees. The company is highly rated for salary & benefits, job security and skill development, based on 6,200+ employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Helping over 1 Crore job seekers every month in choosing their right fit company
80 Lakh+
Reviews
6 Lakh+
Interviews
4 Crore+
Salaries
1 Cr+
Users/Month
Contribute to help millions
Get AmbitionBox app